Related Experiment Videos
The potential for recruiting immune responses toward type 1 or type 2 T cell help
B Golding1, M Zaitseva, H Golding
1Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland.
The American Journal of Tropical Medicine and Hygiene
|January 1, 1994
Summary
Malaria vaccine design requires balancing T helper 1 (TH1) and T helper 2 (TH2) cell responses. Targeting specific parasite stages and using carriers like Brucella abortus can promote a protective TH1 bias.
Area of Science:
- Immunology
- Vaccinology
- Parasitology
Background:
- Vaccine development necessitates understanding T helper (TH) cell subset balance.
- TH1 cells drive cell-mediated immunity (CMI) crucial for intracellular parasite defense.
- TH2 cells promote antibody responses but offer limited CMI, potentially increasing infection susceptibility.
Purpose of the Study:
- To explore strategies for manipulating immune responses to achieve a protective TH1 bias in malaria vaccine design.
- To identify key considerations for targeting specific malaria parasite stages with appropriate immune responses.
Main Methods:
- Reviewing methods to manipulate protein/peptide immune responses, including adjuvants, carriers, cytokines, and administration routes.
- Evaluating the role of specific carriers, such as Brucella abortus, in directing immune responses.
Main Results:
- Brucella abortus is favored as a carrier for focusing antigens and potentially triggering a TH1 cell response.
- Identifying the target parasite stage is critical for tailoring the required TH cell bias.
Conclusions:
- Achieving a protective TH1 bias is essential for effective malaria vaccines.
- Strategic use of carriers and targeting specific parasite stages are key to successful malaria vaccine design.